Konstantinos G. Zeimpekis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Konstantinos G. Zeimpekis has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Axel Rominger
Department of Nuclear Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland
8 shared publications - Hasan Sari
Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
6 shared publications - Gaspar Delso
GE Healthcare, Waukesha, WI USA
5 shared publications - Kuangyu Shi
Department of Nuclear Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland
5 shared publications Axel Rominger
Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland
3 shared publications- Edwin E. G. W. ter Voert
University of Zürich
3 shared publications
Latest Publications
- Open Access
- 12 June 2026
- Published by Springer Nature in EJNMMI Physics
- Vol. 13 (1)
Impact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation
This study compared quantitative accuracy and image quality of post-radioembolization selective internal radiation therapy (SIRT) 90Y PET/CT using a long a
- 12 June 2026
- Published by Springer Nature in EJNMMI Physics
- Vol. 13 (1)
Open AccessImpact of scan duration and scatter correction on quantitative accuracy in Yttrium-90 PET/CT imaging using LAFOV and SAFOV systems: a phantom and clinical evaluation
This study compared quantitative accuracy and image quality of post-radioembolization selective internal radiation therapy (SIRT) 90Y PET/CT using a long a
- Open Access
- 1 December 2025
- Published by Springer Nature in EJNMMI Research
- Vol. 15 (1)
Automation of 99mTc mercaptoacetyltriglycine (MAG3) report writing using a vision language model
99mTc mercaptoacetyltriglycine (MAG3) studies represent a classic of nuclear medicine. We evaluated the quality of MAG3 reports generated by a vision langu
- 1 December 2025
- Published by Springer Nature in EJNMMI Research
- Vol. 15 (1)
Open AccessAutomation of 99mTc mercaptoacetyltriglycine (MAG3) report writing using a vision language model
99mTc mercaptoacetyltriglycine (MAG3) studies represent a classic of nuclear medicine. We evaluated the quality of MAG3 reports generated by a vision langu
- Open Access
- 28 December 2024
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (4) , 1460-1471
Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging
Purpose: Long axial field-of-view (LAFOV) positron emission tomography/computed tomography (PET/CT) scanners enable high sensitivity and wide anatomical coverage. Therefore, they seem ideal to perform post-selective internal radiation therapy (SIRT) 90Y scans, which are needed, to confirm that the dose is delivered to the tumors and that healthy organs are spared. However, it is unclear to what extent the use of LAFOV PET is feasible and which dosimetry approaches results in accurate measurements. Methods: In this retrospective analysis, a total number of 32 patients was included (median age 71, IQR 14), which had hepatocellular carcinoma, cholangiocarcinoma, or liver metastases. All patients underwent SIRT, and the post-therapy scan was acquired on a single photon emission computed tomography/computed tomography (SPECT/CT) and a LAFOV Biograph Quadra PET/CT with a 20-minute acquisition time. Post-treatment dosimetry, regarding the tumor, whole-liver and lung (LMD) absorbed dose was done using an organ-wise (Simplicit90Y) and a voxel-wise approach (HERMIA Dosimetry) which used a semi-Monte Carlo algorithm. The lung shunt fraction (LSF) was also measured using the voxel-wise approach and compared to the planned. Results: The planning, post-treatment SPECT and PET (SPECTpre, SPECTpost, PETpost) median tumor doses based on the organ-wise dosimetry were 276.0 Gy (200.0–330.0 Gy), 232.0 Gy (158.5–303.5 Gy) and 267.5 Gy (182.5–370.8 Gy). In contrast, the median voxel-wise PETpost dose was significantly smaller than the planned SPECTpre (152.5 Gy (94.8–223.8 Gy); p < 0.00001). Moreover, the median tumor absorbed dose at 90% (D90) of the tumor volume was significantly higher in SPECTpost compared with PETpost (123.5 Gy; 81.5–180.0 vs. 30.5 Gy; 11.3-106.3; p < 0.00001). The PETpost measured LSF was significantly lower compared to the planned SPECTpre (0.89%; 0.4–1.3% vs. 2.3%; 1.5–3.6%; p < 0.0001). Similarly, the measured PETpost median LMD was considerably lower to the planned SPECTpre (1.2 Gy; 0.6–2.3 vs. 2.5 Gy; 1.4–4.7; p < 0.0001). Conclusion: LAFOV PET enabled the direct measurement of post therapy lung dose and tumor doses that correlated well with the planned treatment doses. However, current voxel-wise-based tumor dosimetry seems to be inaccurate for LAFOV PET. In addition, dose volume histogram-based metrics also significantly underestimate the delivered dose. Therefore, improved dosimetry tools are needed for reliable voxel-wise 90Y dosimetry to leverage the sensitivity and spatial resolution of LAFOV PET scanners.
- 28 December 2024
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (4) , 1460-1471
Open AccessEvaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imaging
Purpose: Long axial field-of-view (LAFOV) positron emission tomography/computed tomography (PET/CT) scanners enable high sensitivity and wide anatomical coverage. Therefore, they seem ideal to perform post-selective internal radiation therapy (SIRT) 90Y scans, which are needed, to confirm that the dose is delivered to the tumors and that healthy organs are spared. However, it is unclear to what extent the use of LAFOV PET is feasible and which dosimetry approaches results in accurate measurements. Methods: In this retrospective analysis, a total number of 32 patients was included (median age 71, IQR 14), which had hepatocellular carcinoma, cholangiocarcinoma, or liver metastases. All patients underwent SIRT, and the post-therapy scan was acquired on a single photon emission computed tomography/computed tomography (SPECT/CT) and a LAFOV Biograph Quadra PET/CT with a 20-minute acquisition time. Post-treatment dosimetry, regarding the tumor, whole-liver and lung (LMD) absorbed dose was done using an organ-wise (Simplicit90Y) and a voxel-wise approach (HERMIA Dosimetry) which used a semi-Monte Carlo algorithm. The lung shunt fraction (LSF) was also measured using the voxel-wise approach and compared to the planned. Results: The planning, post-treatment SPECT and PET (SPECTpre, SPECTpost, PETpost) median tumor doses based on the organ-wise dosimetry were 276.0 Gy (200.0–330.0 Gy), 232.0 Gy (158.5–303.5 Gy) and 267.5 Gy (182.5–370.8 Gy). In contrast, the median voxel-wise PETpost dose was significantly smaller than the planned SPECTpre (152.5 Gy (94.8–223.8 Gy); p < 0.00001). Moreover, the median tumor absorbed dose at 90% (D90) of the tumor volume was significantly higher in SPECTpost compared with PETpost (123.5 Gy; 81.5–180.0 vs. 30.5 Gy; 11.3-106.3; p < 0.00001). The PETpost measured LSF was significantly lower compared to the planned SPECTpre (0.89%; 0.4–1.3% vs. 2.3%; 1.5–3.6%; p < 0.0001). Similarly, the measured PETpost median LMD was considerably lower to the planned SPECTpre (1.2 Gy; 0.6–2.3 vs. 2.5 Gy; 1.4–4.7; p < 0.0001). Conclusion: LAFOV PET enabled the direct measurement of post therapy lung dose and tumor doses that correlated well with the planned treatment doses. However, current voxel-wise-based tumor dosimetry seems to be inaccurate for LAFOV PET. In addition, dose volume histogram-based metrics also significantly underestimate the delivered dose. Therefore, improved dosimetry tools are needed for reliable voxel-wise 90Y dosimetry to leverage the sensitivity and spatial resolution of LAFOV PET scanners.
- 30 November 2024
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 55 (1) , 98-106
Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging
- 30 November 2024
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 55 (1) , 98-106
Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging
- Open Access
- 1 October 2024
- Published by Springer Nature in Research Square
Evaluation of Long Axial Field-of-View (LAFOV) PET/CT for Post-Treatment Dosimetry in Yttrium-90 Radioembolization of Liver Tumors: A Comparative Study with Conventional SPECT Imaging
Purpose Long axial field-of-view (LAFOV) PET/CT scanners enable high sensitivity and wide anatomical coverage. Therefore, they seem ideal to perform post-selective internal radiation therapy (SIRT) 90Y scans, which are needed, to confirm that the dose is delivered to the tumors and that healthy organs are spared. However, it is unclear to what extent the use of LAFOV PET is feasible and which dosimetry approaches results in accurate measurements. Methods In this retrospective analysis, a total number of 32 patients was included (median age 71, IQR 64-76), which had HCC, CCC or liver metastases. All patients underwent SIRT, and the post-therapy scan was acquired on a SPECT/CT and a LAFOV Biograph Quadra PET/CT with a 20-minute acquisition time. Post-treatment dosimetry, regarding the tumor, whole-liver and lung (LMD) absorbed dose was done using an organ-wise (Simplicit90Y) and a voxel-wise approach (HERMIA Dosimetry) which used a semi-Monte Carlo algorithm. The lung shunt fraction (LSF) was also measured using the voxel-wise approach and compared to the planned. Results The planning, post-treatment SPECT and PET (SPECTpre, SPECTpost, PETpost) median tumor doses based on the organ-wise dosimetry were 276.0 Gy (200.0-330.0 Gy), 232.0 Gy (158.5-303.5 Gy) and 267.5 Gy (182.5-370.8 Gy). In contrast, the median voxel-wise PETpost dose was significantly smaller than the planned SPECTpre (152.5 Gy (94.8-223.8 Gy); ppost compared with PETpost (123.5 Gy; 81.5 -180.0 vs. 30.5 Gy; 11.3-106.3; p < 0.00001). The PETpost measured LSF was significantly lower compared to the planned SPECTpre (0.89%; 0.4-1.3% vs. 2.3%; 1.5-3.6%; ppost median LMD was considerably lower to the planned SPECTpre (1.2 Gy; 0.6-2.3 vs. 2.5 Gy; 1.4-4.7; p90Y dosimetry to leverage the sensitivity and spatial resolution of LAFOV PET scanners.
- 1 October 2024
- Published by Springer Nature in Research Square
Open AccessEvaluation of Long Axial Field-of-View (LAFOV) PET/CT for Post-Treatment Dosimetry in Yttrium-90 Radioembolization of Liver Tumors: A Comparative Study with Conventional SPECT Imaging
Purpose Long axial field-of-view (LAFOV) PET/CT scanners enable high sensitivity and wide anatomical coverage. Therefore, they seem ideal to perform post-selective internal radiation therapy (SIRT) 90Y scans, which are needed, to confirm that the dose is delivered to the tumors and that healthy organs are spared. However, it is unclear to what extent the use of LAFOV PET is feasible and which dosimetry approaches results in accurate measurements. Methods In this retrospective analysis, a total number of 32 patients was included (median age 71, IQR 64-76), which had HCC, CCC or liver metastases. All patients underwent SIRT, and the post-therapy scan was acquired on a SPECT/CT and a LAFOV Biograph Quadra PET/CT with a 20-minute acquisition time. Post-treatment dosimetry, regarding the tumor, whole-liver and lung (LMD) absorbed dose was done using an organ-wise (Simplicit90Y) and a voxel-wise approach (HERMIA Dosimetry) which used a semi-Monte Carlo algorithm. The lung shunt fraction (LSF) was also measured using the voxel-wise approach and compared to the planned. Results The planning, post-treatment SPECT and PET (SPECTpre, SPECTpost, PETpost) median tumor doses based on the organ-wise dosimetry were 276.0 Gy (200.0-330.0 Gy), 232.0 Gy (158.5-303.5 Gy) and 267.5 Gy (182.5-370.8 Gy). In contrast, the median voxel-wise PETpost dose was significantly smaller than the planned SPECTpre (152.5 Gy (94.8-223.8 Gy); ppost compared with PETpost (123.5 Gy; 81.5 -180.0 vs. 30.5 Gy; 11.3-106.3; p < 0.00001). The PETpost measured LSF was significantly lower compared to the planned SPECTpre (0.89%; 0.4-1.3% vs. 2.3%; 1.5-3.6%; ppost median LMD was considerably lower to the planned SPECTpre (1.2 Gy; 0.6-2.3 vs. 2.5 Gy; 1.4-4.7; p90Y dosimetry to leverage the sensitivity and spatial resolution of LAFOV PET scanners.
- Open Access
- 13 February 2024
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (7) , 2100-2113
90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry
Purpose: Evaluation of 90Y liver radioembolization post-treatment clinical data using a whole-body Biograph Vision Quadra PET/CT to investigate the potential of protocol optimization in terms of scan time and dosimetry. Methods: 17 patients with hepatocellular carcinoma with median (IQR) injected activity 2393 (1348–3298) MBq were included. Pre-treatment dosimetry plan was based on 99mTc-MAA SPECT/CT with Simplicit90Y™ and post-treatment validation with Quadra using Simplicit90Y™ and HERMIA independently. Regarding the image analysis, mean and peak SNR, the coefficient of variation (COV) and lesion-to-background ratio (LBR) were evaluated. For the post-treatment dosimetry validation, the mean tumor, whole liver and lung absorbed dose evaluation was performed using Simplicit90Y and HERMES. Images were reconstructed with 20-, 15-, 10-, 5- and 1- min sinograms with 2, 4, 6 and 8 iterations. Wilcoxon signed rank test was used to show statistical significance (p < 0.05). Results: There was no difference of statistical significance between 20- and 5- min reconstructed times for the peak SNR, COV and LBR. In addition, there was no difference of statistical significance between 20- and 1- min reconstructed times for all dosimetry metrics. Lung dosimetry showed consistently lower values than the expected. Tumor absorbed dose based on Simplicit90Y™ was similar to the expected while HERMES consistently underestimated significantly the measured tumor absorbed dose. Finally, there was no difference of statistical significance between expected and measured tumor, whole liver and lung dose for all reconstruction times. Conclusion: In this study we evaluated, in terms of image quality and dosimetry, whole-body PET clinical images of patients after having been treated with 90Y microspheres radioembolization for liver cancer. Compared to the 20-min standard scan, the simulated 5-min reconstructed images provided equal image peak SNR and noise behavior, while performing also similarly for post-treatment dosimetry of tumor, whole liver and lung absorbed doses.
- 13 February 2024
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (7) , 2100-2113
Open Access90Y post-radioembolization clinical assessment with whole-body Biograph Vision Quadra PET/CT: image quality, tumor, liver and lung dosimetry
Purpose: Evaluation of 90Y liver radioembolization post-treatment clinical data using a whole-body Biograph Vision Quadra PET/CT to investigate the potential of protocol optimization in terms of scan time and dosimetry. Methods: 17 patients with hepatocellular carcinoma with median (IQR) injected activity 2393 (1348–3298) MBq were included. Pre-treatment dosimetry plan was based on 99mTc-MAA SPECT/CT with Simplicit90Y™ and post-treatment validation with Quadra using Simplicit90Y™ and HERMIA independently. Regarding the image analysis, mean and peak SNR, the coefficient of variation (COV) and lesion-to-background ratio (LBR) were evaluated. For the post-treatment dosimetry validation, the mean tumor, whole liver and lung absorbed dose evaluation was performed using Simplicit90Y and HERMES. Images were reconstructed with 20-, 15-, 10-, 5- and 1- min sinograms with 2, 4, 6 and 8 iterations. Wilcoxon signed rank test was used to show statistical significance (p < 0.05). Results: There was no difference of statistical significance between 20- and 5- min reconstructed times for the peak SNR, COV and LBR. In addition, there was no difference of statistical significance between 20- and 1- min reconstructed times for all dosimetry metrics. Lung dosimetry showed consistently lower values than the expected. Tumor absorbed dose based on Simplicit90Y™ was similar to the expected while HERMES consistently underestimated significantly the measured tumor absorbed dose. Finally, there was no difference of statistical significance between expected and measured tumor, whole liver and lung dose for all reconstruction times. Conclusion: In this study we evaluated, in terms of image quality and dosimetry, whole-body PET clinical images of patients after having been treated with 90Y microspheres radioembolization for liver cancer. Compared to the 20-min standard scan, the simulated 5-min reconstructed images provided equal image peak SNR and noise behavior, while performing also similarly for post-treatment dosimetry of tumor, whole liver and lung absorbed doses.
- Open Access
- 27 January 2024
- Published by Elsevier in Physica Medica
- Vol. 118, 103296
Phantom study for 90Y liver radioembolization dosimetry with a long axial field-of-view PET/CT
- 27 January 2024
- Published by Elsevier in Physica Medica
- Vol. 118, 103296
Open AccessPhantom study for 90Y liver radioembolization dosimetry with a long axial field-of-view PET/CT
- Open Access
- 12 December 2022
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 50 (4) , 1168-1182
Phantom-based evaluation of yttrium-90 datasets using biograph vision quadra
Purpose: The image quality characteristics of two NEMA phantoms with yttrium-90 (90Y) were evaluated on a long axial field-of-view (AFOV) PET/CT. The purpose was to identify the optimized reconstruction setup for the imaging of patients with hepatocellular carcinoma after 90Y radioembolization. Methods: Two NEMA phantoms were used, where one had a 1:10 sphere to background activity concentration ratio and the second had cold background. Reconstruction parameters used are as follows: iterations 2 to 8, Gaussian filter 2- to 6-mm full-width-at-half-maximum, reconstruction matrices 440 × 440 and 220 × 220, high sensitivity (HS), and ultra-high sensitivity (UHS) modes. 50-, 40-, 30-, 20-, 10-, and 5-min acquisitions were reconstructed. The measurements included recovery coefficients (RC), signal-to-noise ratio (SNR), background variability, and lung error which measures the residual error in the corrections. Patient data were reconstructed with 20-, 10-, 5-, and 1-min time frames and evaluated in terms of SNR. Results: The RC for the hot phantom was 0.36, 0.45, 0.53, 0.63, 0.68, and 0.84 for the spheres with diameters of 10, 13, 17, 22, 28, and 37 mm, respectively, for UHS 2 iterations, a 220 × 220 matrix, and 50-min acquisition. The RC values did not differ with acquisition times down to 20 min. The SNR was the highest for 2 iterations, measured 11.7, 16.6, 17.6, 19.4, 21.9, and 27.7 while the background variability was the lowest (27.59, 27.08, 27.36, 26.44, 30.11, and 33.51%). The lung error was 18%. For the patient dataset, the SNR was 19%, 20%, 24%, and 31% higher for 2 iterations compared to 4 iterations for 20-, 10-, 5-, and 1-min time frames, respectively. Conclusions: This study evaluates the NEMA image quality of a long AFOV PET/CT scanner with 90Y. It provides high RC for the smallest sphere compared to other standard AFOV scanners at shorter scan times. The maximum patient SNR was for 2 iterations, 20 min, while 5 min delivers images with acceptable SNR.
- 12 December 2022
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 50 (4) , 1168-1182
Open AccessPhantom-based evaluation of yttrium-90 datasets using biograph vision quadra
Purpose: The image quality characteristics of two NEMA phantoms with yttrium-90 (90Y) were evaluated on a long axial field-of-view (AFOV) PET/CT. The purpose was to identify the optimized reconstruction setup for the imaging of patients with hepatocellular carcinoma after 90Y radioembolization. Methods: Two NEMA phantoms were used, where one had a 1:10 sphere to background activity concentration ratio and the second had cold background. Reconstruction parameters used are as follows: iterations 2 to 8, Gaussian filter 2- to 6-mm full-width-at-half-maximum, reconstruction matrices 440 × 440 and 220 × 220, high sensitivity (HS), and ultra-high sensitivity (UHS) modes. 50-, 40-, 30-, 20-, 10-, and 5-min acquisitions were reconstructed. The measurements included recovery coefficients (RC), signal-to-noise ratio (SNR), background variability, and lung error which measures the residual error in the corrections. Patient data were reconstructed with 20-, 10-, 5-, and 1-min time frames and evaluated in terms of SNR. Results: The RC for the hot phantom was 0.36, 0.45, 0.53, 0.63, 0.68, and 0.84 for the spheres with diameters of 10, 13, 17, 22, 28, and 37 mm, respectively, for UHS 2 iterations, a 220 × 220 matrix, and 50-min acquisition. The RC values did not differ with acquisition times down to 20 min. The SNR was the highest for 2 iterations, measured 11.7, 16.6, 17.6, 19.4, 21.9, and 27.7 while the background variability was the lowest (27.59, 27.08, 27.36, 26.44, 30.11, and 33.51%). The lung error was 18%. For the patient dataset, the SNR was 19%, 20%, 24%, and 31% higher for 2 iterations compared to 4 iterations for 20-, 10-, 5-, and 1-min time frames, respectively. Conclusions: This study evaluates the NEMA image quality of a long AFOV PET/CT scanner with 90Y. It provides high RC for the smallest sphere compared to other standard AFOV scanners at shorter scan times. The maximum patient SNR was for 2 iterations, 20 min, while 5 min delivers images with acceptable SNR.
- Open Access
- 6 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Using domain knowledge for robust and generalizable deep learning-based CT-free PET attenuation and scatter correction
Despite the potential of deep learning (DL)-based methods in substituting CT-based PET attenuation and scatter correction for CT-free PET imaging, a critical bottleneck is their limited capability in handling large heterogeneity of tracers and scanners of PET imaging. This study employs a simple way to integrate domain knowledge in DL for CT-free PET imaging. In contrast to conventional direct DL methods, we simplify the complex problem by a domain decomposition so that the learning of anatomy-dependent attenuation correction can be achieved robustly in a low-frequency domain while the original anatomy-independent high-frequency texture can be preserved during the processing. Even with the training from one tracer on one scanner, the effectiveness and robustness of our proposed approach are confirmed in tests of various external imaging tracers on different scanners. The robust, generalizable, and transparent DL development may enhance the potential of clinical translation.
- 6 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-9
Open AccessUsing domain knowledge for robust and generalizable deep learning-based CT-free PET attenuation and scatter correction
Despite the potential of deep learning (DL)-based methods in substituting CT-based PET attenuation and scatter correction for CT-free PET imaging, a critical bottleneck is their limited capability in handling large heterogeneity of tracers and scanners of PET imaging. This study employs a simple way to integrate domain knowledge in DL for CT-free PET imaging. In contrast to conventional direct DL methods, we simplify the complex problem by a domain decomposition so that the learning of anatomy-dependent attenuation correction can be achieved robustly in a low-frequency domain while the original anatomy-independent high-frequency texture can be preserved during the processing. Even with the training from one tracer on one scanner, the effectiveness and robustness of our proposed approach are confirmed in tests of various external imaging tracers on different scanners. The robust, generalizable, and transparent DL development may enhance the potential of clinical translation.
- Open Access
- 10 August 2022
- Published by Springer Nature in Research Square
Phantom-based evaluation of yttrium-90 datasets using Biograph Vision Quadra
Purpose The image quality characteristics of a NEMA body phantom with yttrium-90 were evaluated on a total body PET/CT. The purpose of the study is to identify the optimized reconstruction setup for the imaging protocol of yttrium-90 radioembolization treatment on patients with malignant liver tumors. Methods Two NEMA IEC NU2 body phantoms were used for the study. One was filled with activity concentrations of 0.13 MBq/ml and 1.3 MBq/ml for the background and spheres respectively (ratio 1:10). The second one did not have any background concentration but had similar concentration for the spheres. Scan time was 50 minutes and the phantoms were positioned on the same bed and scanned simultaneously. The number of iterations varied from 2 up to 8 (5 subsets), the Gaussian filter from 2mm up to 6mm full-width-at-half-maximum. Images were reconstructed with a matrix of 440 x 440 and 220 x 220, with high sensitivity (HS) and ultra-high sensitivity (UHS) modes with the improved 3D scatter correction method. We simulated shorter acquisition times based on the list-mode data with 40, 30, 20, 10 and 5-minutes. The measurements included contrast recovery coefficients, signal-to-noise ratio, background variability and lung error. List mode data of a patient were rebinned in 1, 5, 10 and 20 minute time frames and evaluated. Results The recovery coefficient (RC) for the hot phantom was 0.36, 0.45, 0.53, 0.63, 0.68 and 0.84 for the spheres with diameters of 10, 13, 17, 22, 28, 37 mm respectively for UHS 2 iterations and a 220x220 matrix. The SNR was highest for 2 iterations, measured 11.7, 16.6, 17.6, 19.4, 21.9 and 27.7 and the lung error was 18%. The SNR was 19%, 20%, 24% and 31% higher for 2 iterations compared to 4 iterations for 20, 10, 5 and 1 minutes time frames respectively. Conclusions The long AFOV delivers images of Y-90 with the smallest sphere well visualized with a high RC. SNR for the patient data was maximum for 2 iterations and for 20-minutes acquisition while even 5-minutes acquisition time delivers images with no great loss of SNR (-20%). Further clinical investigation is recommended to check also the effects on post-treatment dosimetry validation.
- 10 August 2022
- Published by Springer Nature in Research Square
Open AccessPhantom-based evaluation of yttrium-90 datasets using Biograph Vision Quadra
Purpose The image quality characteristics of a NEMA body phantom with yttrium-90 were evaluated on a total body PET/CT. The purpose of the study is to identify the optimized reconstruction setup for the imaging protocol of yttrium-90 radioembolization treatment on patients with malignant liver tumors. Methods Two NEMA IEC NU2 body phantoms were used for the study. One was filled with activity concentrations of 0.13 MBq/ml and 1.3 MBq/ml for the background and spheres respectively (ratio 1:10). The second one did not have any background concentration but had similar concentration for the spheres. Scan time was 50 minutes and the phantoms were positioned on the same bed and scanned simultaneously. The number of iterations varied from 2 up to 8 (5 subsets), the Gaussian filter from 2mm up to 6mm full-width-at-half-maximum. Images were reconstructed with a matrix of 440 x 440 and 220 x 220, with high sensitivity (HS) and ultra-high sensitivity (UHS) modes with the improved 3D scatter correction method. We simulated shorter acquisition times based on the list-mode data with 40, 30, 20, 10 and 5-minutes. The measurements included contrast recovery coefficients, signal-to-noise ratio, background variability and lung error. List mode data of a patient were rebinned in 1, 5, 10 and 20 minute time frames and evaluated. Results The recovery coefficient (RC) for the hot phantom was 0.36, 0.45, 0.53, 0.63, 0.68 and 0.84 for the spheres with diameters of 10, 13, 17, 22, 28, 37 mm respectively for UHS 2 iterations and a 220x220 matrix. The SNR was highest for 2 iterations, measured 11.7, 16.6, 17.6, 19.4, 21.9 and 27.7 and the lung error was 18%. The SNR was 19%, 20%, 24% and 31% higher for 2 iterations compared to 4 iterations for 20, 10, 5 and 1 minutes time frames respectively. Conclusions The long AFOV delivers images of Y-90 with the smallest sphere well visualized with a high RC. SNR for the patient data was maximum for 2 iterations and for 20-minutes acquisition while even 5-minutes acquisition time delivers images with no great loss of SNR (-20%). Further clinical investigation is recommended to check also the effects on post-treatment dosimetry validation.